There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...

Medicare is prohibited by law from covering GLP-1 drugs for weight loss. But many beneficiaries can access the drugs anyway.

After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has been ...

Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...

After psychological side effects doomed the first generation of cannabinoid receptor 1–targeting drugs for weight loss, Novo ...

The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...

More severe side effects can include pancreatitis, vision changes, allergic reactions, fatigue or dizziness, gallstones, ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Muth is a primary care pediatrician and obesity medicine ...

a class of obesity drugs (e.g., Ozempic) that mimic a gut hormone, GLP-1, to increase insulin release. Originally approved for Type 2 diabetes, the drug has been shown to suppress appetite and reduce ...

WW stock popped after announcing a new compounded semaglutide product to benefit from the current shortage of weight loss ...